Resultados de la búsqueda

Desai MY, Okushi Y, Jadam S, Olivotto I, Owens A, Nissen SE, Popovic ZB, Garcia-Pavia P, Lopes RD, Elliott PM, Fernandes F, Geske JB, Maier L, Wolski K, Wang Q, Jaber W, Gong Z, Florea V, Fronheiser M, Leva A, Aronson R, Abraham T; ODYSSEY-HCM Investigators. Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM Trial. J Am Coll Cardiol (2025) 86:2434-2449

Hegde SM, Wang X, Garcia-Pavia P, Getchevski S, Masri A, Merkely B, Nassif ME, Peña-Peña ML, Barriales-Villa R, Bilen O, Burroughs M, Claggett B, Costabel JP, Correia EB, Dybro AM, Elliott P, Lakdawala NK, Mann A, Maron MS, Nair A, Poulsen SH, Reant P, Schulze PC, Wang A, Sohn R, Berhane I, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Wohltman A, Fifer MA, Solomon SD; MAPLE-HCM Investigators. Effect of Aficamten Compared With Metoprolol on Echocardiographic Measures in Symptomatic Obstructive Hypertrophic Cardiomyopathy: MAPLE-HCM. J Am Coll Cardiol (2025) 86:2452-2467

Carreño-Tarragona G, Tiana M, Rouco R, Leivas A, Victorino J, García-Vicente R, Chase AJ, Maidana A, Tapper WJ, Ayala R, Cross NCP, Martínez-López J, Manzanares M. The JAK2 46/1 haplotype influences PD-L1 expression. Blood (2025) 145:2196-2201

Lalaguna L, Arévalo-Núñez de Arenas M, López-Olañeta M, Villalba-Orero M, Jiménez-Riobóo RJ, Gómez-Gaviro MV, Isern J, Muñoz-Cánoves P, Byrne BJ, Ochoa JP, García-Pavía P, Lara-Pezzi E. Overexpression of Wild-Type TMEM43 Improves Cardiac Function in Arrhythmogenic Right Ventricular Cardiomyopathy Type 5. Circ Res (2025) 136:830-84
Link to the full text in Repisalud

Devesa A, Delgado V, Valkovic L, Lima JAC, Nagel E, Ibanez B, Raman B. Multiorgan Imaging for Interorgan Crosstalk in Cardiometabolic Diseases. Circ Res (2025) 136:1454-1475

Galán M, Fernández-Méndez L, Núñez V, Femenía-Muiña M, Figuera-Belmonte P, Moya-Ruiz E, Martínez-Cano S, Hernández-García E, Rodrigo-Tapias M, Rodríguez-Ronchel A, Relaño-Rupérez C, Wculek SK, Benguria A, Dopazo A, Henri S, Jo S, Liu TT, Malissen B, Murphy KM, Ramiro AR, Carregal-Romero S, Ruiz-Cabello J, Robles-Vera I, Sancho D. cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy. Circ Res (2025) 137:400-416

Vázquez-Reyes S, García-Culebras A, Di G, De Castro-Millán FJ, Díaz-Benito B, Nieto-Vaquero C, Ruiz-Sanchez A, Merino-Casamayor E, Parra-Pérez C, Moraga A, Core-Barrera C, Calleja P, Dopazo A, Callejas S, Rubio-Ponce A, Aroca-Crevillén A, Sánchez-Cabo F, Pascual El Bobakry S, Torroja C, Esposito E, Lo EH, Ballesteros I, Hidalgo A, Cuartero MI, Lizasoain I, Moro MÁ. Circadian Control of Neutrophils Drives Collateral Perfusion and Stroke Outcome. Circ Res (2025) Nov 26 [Epub ahead of print]

Yilmaz B, Baertschi I, Meier KHU, Le Gac C, Jordi SBU, Black C, Li J, Lindholm AK; International Mouse Microbiota Investigators; König B, Sauer U, Stelling J, Macpherson AJ. A global survey of taxa-metabolic associations across mouse microbiome communities. Cell Host Microbe (2025) 33:1960-1976
Link to the full text in Repisalud

Van Linthout S, Stellos K, Giacca M, Bertero E, Cannata A, Carrier L, Garcia-Pavia P, Ghigo A, González A, Haugaa KH, Imazio M, Lopes LR, Most P, Pollesello P, Schunkert H, Streckfuss-Bömeke K, Thum T, Tocchetti CG, Tschöpe C, van der Meer P, van Rooij E, Metra M, Rosano GMC, Heymans S. State of the art and perspectives of gene therapy in heart failure. A scientific statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases. Eur J Heart Fail (2025) 27:5-25

Ghigo A, Ameri P, Asnani A, Bertero E, de Boer RA, Farmakis D, González A, Heymans S, Ibáñez B, López-Fernández T, Lyon AR, Pollesello P, Rakisheva A, Stellos K, Streckfuss-Bömeke K, Tocchetti CG, Thum T, van der Meer P, Van Rooij E, Ponikowski P, Metra M, Rosano G, Van Linthout S. Update on preclinical models of cancer therapy-related cardiac dysfunction: Challenges and perspectives. A scientific statement of the Heart Failure Association (HFA) of the ESC, the ESC Council of Cardio-Oncology, and the ESC Working Group on Cellular Biology of the Heart. Eur J Heart Fail (2025) 27:1028-1046
Link to the full text in Repisalud